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Baseline characteflstics were similar in both groups except fur slightly older 
patients (62 vs 59 yr) and more prior infarctions (17 vs 13%) in the no-PTCA 
cohort. Them were more patients with multivesaol disease (51 vs 37%) and 
Killlp class > II (16 vs 10%) in the no-PTCA COhort, while the PTCA COhort 
had a higher incidence of TIMI 0-2 flow (58 vs 47%). 
PTCA No PTCA p -~ 
fn-hospftst rnort~Ity (%} 3 8 <0,001 
30-day moItality (%) 3 8 <0.001 
CHF (%) 14 17 <0.001 
Re-infarctmn (%) 7 3 <0,001 
Conclusion: After an acute myocardial infarction, percutanesus revascuL~r- 
~.ation appears to be associated with lower mortality end higher e-infarction 
tutus. This association is COnfounded by the lower risk of PTCA patients at 
the time of mndomtzetion end the more COmmon use of PTCA for occluded 
arteries. 
~-~"6"]  Primary Angiapiasty Versus Thrombolysis n 
Inferior A©ute Myocardial Infamtten With Anterior 
ST-~ment OepmsMon, a Slngte.Center 
Randomized Study 
F~vio Rtblchtni, Giuseppa Sleftanino, Antonio Dellavatis, Federica Meinardi, 
Anfoneilo Vado, Maum Feola, Eugenio UslenghL ~ Ca lhete~ 
Unit, Cardio/off/ Division, Ospedale Same Croce, Cuneo, Italy 
Repedusion strategies in inferior acute myocardial infarction (IAMI) remain 
controversial. ConCOmitant anterior ST depression (ASTO) is commonly as- 
soctatod with a poorer prognosis at both short and long-=ann, and aggressive 
mparfusion strataglas are advised In this setting. Two reperfusion strategies 
were COmpared prospectively with a randomized protocol. The initial results 
of the acute.phase of this study are presented. 
Between Janumy 1994 and Jury 1995 fifty patients with IAMI and ASTD (> 
4 mm V1-V4) were admitted within 6 hours of symptoms, and randomized to 
primary PTCA {Group A = 24 patients), or lyric therapy following the GUSTO 
protocol (Group B = 26 patients). The 2 groups were similar as to age, sex, risk 
factom, prior AMI, interval from onset of symptoms, and clinical presentation. 
PTCA was successful in all patients, None died. Ischemic omplications (re- 
infarction and recurrence of angina at rest) occurred in tn 1 patient (4%) in 
group A vs 10 patients (38%) in group B (p = 0.010). Congestive bea,-t failure 
during husp'dal stay was present in I patient (4%) in group A vs. 5 (19%) in 
group B. Pra-discharge asg~y was performed in ait patients. In group A 
it showed: TIM! 3 flow grade in ati cases, and left ventricolar ejection fraction 
54.7:1:10%. In group B aTIMI 3 flow was present in 19 patients and ejection 
fraction was 42.5 + -12%. (p < 0.001). Hospital stay was 9.2 + -3  clays in 
group A vs. 14.8 + -3  days in group B (p = < 0.001}. 
In conclusion: IAMIs with ASTD are large infastion~ with a high rate of com- 
plications; pdman/PTCA may reduce in-hospital complications and hospital- 
stay, with better myocardial preservation as COmpared to lyric therapy. 
( '9"~ To Achieve a Bigger Diameter to and Prevent the 
Recoil of the Lumen Contribute to the Preventten 
of Coronary Reo~lusion After Successful 
Recanalizalion I  Acute Myocardial Infarction 
Shigeru Saito, George Hoeskawa, Shinjl Tanaka, Shogo Miyake, Shonen 
Kamakura General Hospital, Kamakura, Japan 
To test the hypothesis that it is neceesmy for the prevention of the reocc~usion 
to achieve a bigger luminal diameter and to prevent he luminal recoil after 
the successful recanaiiz~on o4' the cu!prit comnery artery in acute myosar- 
dial infarction, we ~ the ohasges of minimum lumen diameter (MID) 
between three methods of recanelization; primary Palmaz-Schatz stent irm 
plantation (STENT), primary dimchonal oomnary atherectsmy (DCA), and 
primary COnventional balloon angiop~aaly (POBA). 
Results: 
STENT DCA P09.~ p 
invnedtate/y after ecana/ization; 
N 56 18 5t 
Reference (ram) 3.33 =t: 0.51 3.41 4.0.53 3.22 =t: 0.57 NS 
MLD (ram) 3.30-=-0.40 2844.0.58 2.5t:E0,51 <0.05 
% Stenosis 2.8 :t: 7,2 16.84.13.7 ~.14.11,9 <0.01 
Predischaroe follow-up angiograrn; 
N 55 1,3 48 
Days from onset 11,6 • 2.6 12.6 4.1.6 12.8 :E 3,7 NS 
MLD (ram) 3.11 4. 0.48 2.75 4- 0,47 2.12 4. 0.52 <0.05 
% Sten0sls 5A-t- 10.7 18.94.13.7 33.5~ 11.9 <0.01 
Mean % recoil 5.7 3.2 153 <0.05 
Reoc~usion 0 (0%) 0(0%) 5 (10.9%) <0.05 
Cot~'Jus/on: To achieve a bigger diameter and to prevent he recoit of the 
lumen contribute to the prevention of the reocclusion after the successful 
recanalization i acute myocardial infarction. 
Use of U roki.nese-Coated Hydrogel Balloons for  
Primary Anglopiasty In Patients With Acute 
Myocardial Infarction 
Nawwar Mercho, Kdstin Lynch, Babar Shereef, James J. Glazier, Syad 
A. Abbas, Hans H. Bauer, Jeffrey A. Hitst, Franci~ J. Kieman, Daniel 
B. Fram, Joseph F. Mitchel, Raymond G. McKay. Hartford Hospital, 
University of Connect,  Hartford, CT 
Previous work from our laboratory has documented the efficacy of hydragel. 
coated balloons in the local delivery of umkinase for the trealn',ent of 
theombus-¢onta~ng stanusas. To assess the efficacy of tftis device in pa- 
tlenfs with acute myocam'ial infarction, retrospective angiographi¢ analysis 
was made of 143 consecutive pa~ents undergoing primary angioplnsty. All 
patients worn treated with either oonvontional balloon angioplasly (PTCA; 
n = 73) or with a hydrogel-coated balloon (UK Balloon; n = 70) which had 
been immersed in a concentrated umkinasa solution (50,000 units/oo). The 
study group (mean age 59 :E 4 yrs) inc~eded 97 melee and 46 fe~ who 
wore treated within 12 hours of onset of symptoms. F~een patients (10.5%) 
received thmmboly~c therapy prior to intewention. 
PTCA UK Balloon P Vak:e 
Pre TIMI Flow 1,0 ± 1.3 0.9:1:13 P- 0.80 
Post TIMI Row 2.8 4. 0.3 2.8 ± 0,2 P = 0.50 
Pro Thtombus Score 13 4.1.0 1.6 =t: 1 .O P = 0.017 
Post Thrombus Score 0.3 4. 0.4 0.2 4- 02 P = 0.36 
Final TIMI < 3 12 (16.4%) 8 (11.4%) P = 0.48 
Distal En~olfzation 13 (17,8%) $ (7.1%) P = 0.076 
No Regow 18 (24.6%) 7 (10.0%) P = 0.027 
Res~dva1111rembus 6 (8,2%) 0 (0%) P = 0.028 
Condus/ons: Despite starting with a higher thrombus burden, umkinase. 
coated betioons msu~ed in a lower incklenco Of thmmbetic ompiicatioos 
including no inflow and residual intraluminal c ot. 
Cost Analysis of  Different Management Strategies 
for Myocardial Infamtion 
Bryas C. Donohue, Witliam W. O'Neill, Edc Jackson, Bruce Brodie, 
John Griffin, C. 13aJestrini, Gregg Stone. ~ Wha~n, Denise E. Jones, 
Cindy L Gdnes. Aflegheny Genera/Hes~ Pittsburgh, PA; WTlliam 
Beaumont Hosp#al, Royal Oal~ MI 
Pdmary PTCA has been demonstmtud to be a cost effective method of 
managing patients (pts) with acxde MI (AMI). It I, as been speculated that use 
of acute cath to risk stratify AMI pts would aflo~, for appropriate triage, thus 
avoiding unnecessary admissions to the Coron~,ry Care Unit (CCU), costly 
non~invssive t sting and expediting hospital dis~,ha~. Accordingly, in the 
PAMI II tr~l, after PTCA 908 pie were st~trT~linto tow-risk (LR) and high-risk 
(HR) groups, using clinical and angiogm_phic criterion. After PTCA. LR pts 
wore randomized to CCU ancl standard care or step down unit (SOU) and 
early discharge. As previously reported, the CCU phase of hospitalization 
COuld be safely eliminated and lots could be safely discharged on day 3. 
The HR [0ts were randomized to balloon pump (+IABP) vs no balloon pump 
(-IABP). +IABP did not reduce death or recurrent M! but did reduce recurrent 
ischemia nd norvpmtocol ca~. Cost analysis was performed. 
LOS" Cost  Reimbursement °" 
Low-RP.k Pa*~s 
CCU 6.8 days $12,945 $10,790 
SDU 4.2 days $11o338 $10,268 
p value 0.0001 0,C2 NS 
HCh.Risk Pagents 
+IABP 10.3 days $19,462 $23,160 
-IABP 9.6 days $17.463 $18,334 
p value NS NS 0,03 
• Length of stay. "Hosp~! reimbursen'r,J~ tot PAMI II stay 
Thus, among HR pts, +IABP reduced lschemia nd inc=aased hospital re* 
imbursament. Among LR 10is, CCU admission is not necessary and increases 
COSt. 
!ilZ:!~ii:,d 
ii!~iE 
